Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder cancer: deciding on appropriate surgery.

D P Wood1, J E Montie

  • 1Memorial Sloan-Kettering.

Oncology (Williston Park, N.Y.)
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction With a Survivorship Program Embedded in Urologic-Oncologic Care.

Urology·2021
Same author

Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.

Prostate cancer and prostatic diseases·2016
Same author

Pedestrian head translation, rotation and impact velocity: the influence of vehicle speed, pedestrian speed and pedestrian gait.

Accident; analysis and prevention·2012
Same author

Review article Salvage surgery for locally recurrent prostate cancer after radiation therapy.

Urologic oncology·2011
Same author

Interobserver consistency of digital rectal examination in clinical staging of localized prostatic carcinoma.

Urologic oncology·2011
Same author

Hypnosis with the surgical patient.

Military medicine·2010
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Surgery remains crucial for bladder cancer staging and treatment, evolving into a multimodal approach. While bladder-sparing techniques and improved diversions enhance quality of life, advanced stages require further chemotherapy research for better survival.

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • The management of bladder cancer has significantly evolved over the past four decades.
  • Surgery was historically the sole treatment but is now integrated into a multimodal strategy.
  • This approach incorporates intravesical and systemic chemotherapy alongside surgical interventions.

Purpose of the Study:

  • To review the evolving role of surgery in bladder cancer management.
  • To highlight advancements in surgical techniques and their impact on patient outcomes.
  • To emphasize the necessity of ongoing research in chemotherapy for advanced bladder cancer.

Main Methods:

  • Review of the historical and current role of surgery in bladder cancer treatment.
  • Discussion of conservative bladder-sparing endoscopic surgery for superficial tumors.

Related Experiment Videos

  • Analysis of continent cutaneous and orthoptic diversions in radical cystectomy patients.

    • Main Results:

    • Surgery remains the cornerstone for staging and treating bladder cancer.
    • Bladder-sparing endoscopic surgery is now a viable option for superficial bladder cancer.
    • Advanced urinary diversions improve quality of life for patients undergoing radical cystectomy.

    Conclusions:

    • Surgery is integral to bladder cancer management, evolving with chemotherapy integration.
    • While surgical advancements improve outcomes for specific stages, they are insufficient for advanced disease.
    • Further research into systemic chemotherapy is essential to improve long-term survival rates in advanced bladder cancer.